Responses to Spike, M and N peptide pools were significantly higher in donors with confirmed SARS-CoV-2 infection compared to subjects with no evidence of infection who displayed relatively weak responses; small responses were also noted in a proportion of HIV-positive subjects with available pre-pandemic samples (Supplementary Fig. 2c). The gene discussed is CHMP5; the disease is infection.